Pharmagreen Biotech Inc (PHBI)
0.0012
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Pharmagreen Biotech Shareholders Equity (Quarterly): -2.104M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -2.104M |
March 31, 2023 | -1.942M |
December 31, 2022 | -1.751M |
September 30, 2022 | -1.776M |
June 30, 2022 | -1.891M |
March 31, 2022 | -2.356M |
December 31, 2021 | -1.538M |
September 30, 2021 | -1.646M |
June 30, 2021 | -1.794M |
Date | Value |
---|---|
March 31, 2021 | -1.824M |
December 31, 2020 | -1.707M |
September 30, 2020 | -2.888M |
June 30, 2020 | -2.238M |
March 31, 2020 | -1.003M |
December 31, 2019 | -1.052M |
September 30, 2019 | -0.8332M |
June 30, 2019 | -0.722M |
September 30, 2018 | -1.388M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.888M
Minimum
Sep 2020
-0.722M
Maximum
Jun 2019
-1.710M
Average
-1.776M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 4.826M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.1403M |
Total Liabilities (Quarterly) | 2.291M |
Debt to Equity Ratio | -0.1898 |
Current Ratio | 0.0237 |